newsfilter
← Latest News
GlobeNewswire·

Finch Therapeutics Announces Executive Leadership Transitions

Matthew P. Blischak, an experienced life sciences executive and intellectual property counsel, appointed as Chief Executive Officer effective May 16, 2023; Mark Smith, PhD, to complete his time as CEO effective May 15